evidoria

← Back to browse

Good practice Imported

Uniseed — Australia's National University Venture Fund

Australia · Brisbane · See the Australia profile · See the Brisbane profile

Evidence: Descriptive / self-reported Top 18% 81/100 · Ask Evidence Copilot about this practice

Australia's oldest university venture fund: since 2000, Uniseed has backed 74 start-ups across nine universities and CSIRO that raised A$1.64bn, including a $700m Novartis exit and a $557.5m Shire exit — though it's open only to wholesale investors.

74 companies
Start-ups backed (2000-2025)
1.64 billion AUD
Capital raised by portfolio companies (cumulative to Nov 2025)
197.6 million AUD
Funds under management (Nov 2025)
700 million USD
Spinifex Pharmaceuticals exit (Novartis) (2015)
557.5 million USD
Fibrotech Therapeutics exit (Shire) (2014)
Uniseed — Australia's National University Venture Fund

Details

Maturity
Established
Promoter
Uniseed (Uniseed Management Pty Ltd)
Period
2000–present
Keywords
technology transfer, university venture capital, biotech and deep-tech spin-outs, IP commercialisation

Context

Uniseed, launched in September 2000 as a $20 million joint venture between the University of Melbourne and the University of Queensland, is Australia's oldest and longest-running early-stage university commercialisation fund. It has since expanded to a nine-university-plus-CSIRO consortium (adding UNSW, University of Sydney, Monash, UTS, University of Newcastle, Macquarie and Western Sydney University).

Objectives

Uniseed invests as the first institutional backer of university spin-outs and licensed IP ahead of traditional VCs.

Activities

Per Uniseed's own November 2025 investor overview, cross-checked against UQ's original 2000 founding press release, the fund operates A$197.6 million in funds under management across a A$57.6m Fund-3, A$20m Follow-On Fund, A$20m Co-Investment Fund and a A$100m UniSuper partnership.

Results

The fund has backed 74 start-ups that have collectively raised A$1.64 billion and employ 1,000+ people. Independently verifiable exits include Spinifex Pharmaceuticals (sold to Novartis, 2015, US$700m), Fibrotech Therapeutics (sold to Shire, 2014, US$557.5m) and Hatchtech (sold to Dr Reddy's, 2015, approx. US$200-279m) — all reported contemporaneously in trade press. Portfolio companies have also secured A$408 million in non-dilutive grant funding and support 1,700+ patents.

Conclusions

Uniseed's own disclosure documents are candid that staff remuneration is partly tied to fundraising success for portfolio companies, and that the fund is restricted to wholesale (sophisticated/institutional) investors, not retail; public figures on total portfolio size and exit counts also vary somewhat by source and date, reflecting different snapshots rather than a single fixed lifetime total.

Implementation
Indicative cost
High (€500k–€5M) — A$197.6 million in funds under management across four vehicles.
Time to results
Long (> 3 years) — Launched September 2000; grew from a 2-university joint venture to a 9-university-plus-CSIRO consortium over 25 years.
Staffing & skills
Managed by Uniseed Management Pty Ltd on behalf of a nine-university-plus-CSIRO consortium

Conditions for success

  • Consortium structure pooling nine universities plus CSIRO and UniSuper, spreading deal flow and capital across a national base
  • First institutional backer of spin-outs ahead of traditional VCs, capturing early-stage IP
  • Multiple fund vehicles (Fund-3, Follow-On Fund, Co-Investment Fund, UniSuper partnership) diversifying capital sources

Common failure modes

  • Fund is restricted to wholesale/institutional investors only, not retail, limiting broader public participation
  • Staff remuneration is partly tied to portfolio fundraising success — a disclosed conflict-of-interest risk typical of captive university funds
  • Public figures on portfolio size and exits vary by source/snapshot rather than a single fixed lifetime total

Where it fits

Governance type
captive university venture-capital consortium (9 universities + CSIRO)
Scale
national (Australia)

Commonly funded by

National / regional programmes

Indicative funding routes for practices of this type — always check each programme's current calls and eligibility rules.

Do you run this practice? Claim it — verified implementers get a public contact pathway and can propose corrections.

Data sources

Where this practice's information was retrieved from, and when.

Attachments

Similar practices you may find useful